Previous 10 | Next 10 |
home / stock / nvmdf / nvmdf news
Following successful clinical pilot, treatment becomes regular offering at Novamind clinics TORONTO, ON / ACCESSWIRE / May 19, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, toda...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 a...
TORONTO, ON / ACCESSWIRE / May 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it has been selected to host a clinical trial for the acute treatment of social anxiet...
Collaboration with HealCommunity Offers Remote Access to Reimbursable Group Therapy Option TORONTO, ON / ACCESSWIRE / May 2, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine...
Healthcare insurance for psychedelics is being explored with more vigor today as patients begin to realize the enormous costs involved in such therapy. Expensive Treatments For example, patients accessing legal MDMA therapy require two licensed therapists, about 20 p...
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research Canada NewsWire Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research si...
New clinic in Phoenix, AZ, offers innovative mental health treatments and group therapy TORONTO, ON / ACCESSWIRE / April 6, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today e...
Bienstar Plans To Build LATAM's First Network of Integrative Mental Health Clinics TORONTO, ON / ACCESSWIRE / March 31, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pl...
Innovative in-person and virtual group offerings increase access to care and social connection TORONTO, ON / ACCESSWIRE / March 24, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedeli...
TORONTO, ON / ACCESSWIRE / March 16, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce it has been selected by Mind Medicine, Inc. (NASDAQ:MNMD), (NEO:MM...
News, Short Squeeze, Breakout and More Instantly...
Novamind Inc. Company Name:
NVMDF Stock Symbol:
OTCMKTS Market:
The pressure is ramping up on the U.S. Drug Enforcement Administration (DEA) as more lawyers, clinicians, researchers, investors and business owners working in the psychedelics industry are demanding clear answers about how the DEA should be evolving on its drug scheduling and e...
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. Numinus shareholders, at a separate meeting held today, have also approved the resolutions related t...